Breaking News, Financial News

Financial Report: Johnson & Johnson 2Q

Worldwide pharmaceutical sales were $5.5 billion in the quarter (-13%), including a 5% negative impact from currency.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Johnson & Johnson 2Q 2Q Revenues: $15.2 billion (-7%) 2Q Earnings: $3.2 billion (-4%) YTD Revenues: $30.3 billion (-7%) YTD Earnings: $6.7 billion (-3%) Comments: Worldwide pharmaceutical sales were $5.5 billion in the quarter (-13%), including a 5% negative impact from currency. Domestic sales were down 16% and international sales were down 9%, the latter of which reflected an operational increase of 3% but a negative currency impact of 12%. Remicade sales were $1.1 billion (...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters